Viewing Study NCT06615193



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06615193
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-19

Brief Title: A Study of HDM2005 in Patients With RelapsedRefractory B-cell Lymphoma and Advanced Solid Tumor
Sponsor: None
Organization: None

Study Overview

Official Title: A Phase IaIb Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of HDM2005 in Patients With RelapsedRefractory B-cell Lymphoma and Advanced Solid Tumor
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a first-in-human FIH study to evaluate the safety and preliminary efficacy of experimental drug HDM2005 in patients with relapsedrefractory B-cell lymphoma and advanced solid tumors
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None